http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03031472-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_886a6eed19ee9de30a2640e774181b7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9da5a39f3c820d3438ca6ac54c0e9e85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41e56aa987f420ec4e41f77af9d41b0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6bda33f2ca1c44eb6a540d1798f95dbd |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-17 |
| filingDate | 2002-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_406569b940eec17767d735e91a3ea832 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1175f4cc69b2319a38cc1b728b2ae30a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3a3d02fa6b1f86eff14ccd1d85520d5 |
| publicationDate | 2003-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-03031472-A2 |
| titleOfInvention | Insulin mimetic amino acid sequences |
| abstract | The invention relates to exsulins or insulin mimetic amino acid sequences with a molecular weight of up to 55,000 daltons and with 1 to 50 basic units of following Formula (I): [-] [L,V,I,A]-X1-X2-[L,V,I,A]-[D,E]-[N,Q,M]-X¿3?-[C,H]-X4 [-], whereby; [L,V,I,A], [D,E], [N,Q,M], [C,H] and X1 to 4 represent peptidically linked amino acids; [L,V,I,A] represents leucine (L), valine (V), isoleucine (I) or alanine (A); [D,E] represents asparaginic acid (D) or glutamic acid (E); [N,Q,M] represents asparagine (N), glutamine (Q) or methionine (M); [C,H] represents cysteine (C) or histidine (H); both groups [L,V,I,A] in a basic unit can be identical or different; X?1, X2, X3 and X4¿ represent any type of amino acid and the four amino acids X1 to 4 in a basic unit can be identical or different. The inventive exsulins can be used in dietetic and pharmaceutical agents, and to be precise, can be used for mimicking the properties and functions of members of the family of endogenous insulin and IGF proteohormones/mediators and for preventing, treating and influencing hormonal states and disturbances as well as various degenerative diseases of the body of mammals including various forms of hormonal metabolic disturbances, hormonal resistances, hormonal deficiencies, hyperinsulinemia, diabetes mellitus and autoimmune diseases as well as neurodegenerative and secondary diseases. |
| priorityDate | 2001-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.